| Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma M Fulciniti, P Tassone, T Hideshima, S Vallet, P Nanjappa, SA Ettenberg, ... Blood, The Journal of the American Society of Hematology 114 (2), 371-379, 2009 | 475 | 2009 |
| Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma RH Prabhala, D Pelluru, M Fulciniti, HK Prabhala, P Nanjappa, W Song, ... Blood, The Journal of the American Society of Hematology 115 (26), 5385-5392, 2010 | 414 | 2010 |
| MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma M Jinushi, M Vanneman, NC Munshi, YT Tai, RH Prabhala, J Ritz, ... Proceedings of the National Academy of Sciences 105 (4), 1285-1290, 2008 | 330 | 2008 |
| Dysfunctional T regulatory cells in multiple myeloma RH Prabhala, P Neri, JE Bae, P Tassone, MA Shammas, CK Allam, ... Blood 107 (1), 301-304, 2006 | 297 | 2006 |
| Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma MK Samur, M Fulciniti, A Aktas Samur, AH Bazarbachi, YT Tai, ... Nature communications 12 (1), 868, 2021 | 286 | 2021 |
| Effect of β-carotene on lymphocyte subpopulations in elderly humans: evidence for a dose-response relationship RR Watson, RH Prabhala, PM Plezia, DS Alberts The American journal of clinical nutrition 53 (1), 90-94, 1991 | 251 | 1991 |
| Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications MA Shammas, P Neri, H Koley, RB Batchu, RC Bertheau, V Munshi, ... Blood 108 (8), 2804-2810, 2006 | 202 | 2006 |
| The effects of 13‐cis‐retinoic acid and beta‐carotene on cellular immunity in humans RH Prabhala, HS Garewal, MJ Hicks, RE Sampliner, RR Watson Cancer 67 (6), 1556-1560, 1991 | 185 | 1991 |
| A high-affinity fully human anti–IL-6 mAb, 1339, for the treatment of multiple myeloma M Fulciniti, T Hideshima, C Vermot-Desroches, S Pozzi, P Nanjappa, ... Clinical Cancer Research 15 (23), 7144-7152, 2009 | 147 | 2009 |
| The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome JJ Driscoll, D Pelluru, K Lefkimmiatis, M Fulciniti, RH Prabhala, PR Greipp, ... Blood, The Journal of the American Society of Hematology 115 (14), 2827-2834, 2010 | 132 | 2010 |
| Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group NS Raje, E Anaissie, SK Kumar, S Lonial, T Martin, MA Gertz, A Krishnan, ... The Lancet Haematology 9 (2), e143-e161, 2022 | 116 | 2022 |
| Enhancement of the expression of activation markers on human peripheral blood mononuclear cells by in vitro culture with retinoids and carotenoids RH Prabhala, V Maxey, MJ Hicks, RR Watson Journal of leukocyte biology 45 (3), 249-254, 1989 | 113 | 1989 |
| A preliminary trial of beta-carotene in subjects infected with the human immunodeficiency virus HS Garewal, NM Ampel, RR Watson, RH Prabhala, CL Dols The Journal of nutrition 122, 728-732, 1992 | 111 | 1992 |
| Functional and numerical alterations induced by ethanol in the cellular immune system SI Mufti, R Prabhala, S Moriguchi, IG Sipes, RR Watson Immunopharmacology 15 (2), 85-94, 1988 | 110 | 1988 |
| Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. RH Prabhala, CR Wira Journal of immunology (Baltimore, Md.: 1950) 155 (12), 5566-5573, 1995 | 109 | 1995 |
| Bortezomib induces anti–multiple myeloma immune response mediated by cGAS/STING pathway activation A Gulla, E Morelli, MK Samur, C Botta, T Hideshima, G Bianchi, M Fulciniti, ... Blood cancer discovery 2 (5), 468-483, 2021 | 99 | 2021 |
| Heat shock protein 90 is critical for regulation of phenotype and functional activity of human T lymphocytes and NK cells J Bae, A Munshi, C Li, M Samur, R Prabhala, C Mitsiades, KC Anderson, ... The Journal of Immunology 190 (3), 1360-1371, 2013 | 80 | 2013 |
| Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma RH Prabhala, M Fulciniti, D Pelluru, N Rashid, A Nigroiu, P Nanjappa, ... Leukemia 30 (2), 379-389, 2016 | 74 | 2016 |
| A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients J Bae, R Prabhala, A Voskertchian, A Brown, C Maguire, P Richardson, ... Leukemia 29 (1), 218-229, 2015 | 74 | 2015 |
| Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophages B Nandi, M Shapiro, MK Samur, C Pai, NY Frank, C Yoon, RH Prabhala, ... Oncoimmunology 5 (8), e1189052, 2016 | 73 | 2016 |
